The present findings using a combination of mouse model of HI (Sur1-/-) and exogenous insulin administration demonstrate the importance of hepatic signaling in glucose homeostasis and the real potential of exploiting glucagon signaling as an untapped resource for treatment of HI associated hypoglycemia. This evidence concerns the gene INS and Hypoglycemia.